Screenings Specifically Recommended for Women: A Practical Overview

Why Women Have Distinct Screening Guidelines

Preventive screenings are not one-size-fits-all. Biological differences, organ-specific cancer risks, and conditions like osteoporosis mean that some tests are recommended specifically — or more frequently — for women. Understanding which screenings apply, and at what ages, helps women prepare informed conversations with their healthcare providers.

For a broader foundation, see what preventive screenings are and why they matter before diving into the specifics below.

Cervical Cancer Screening

Cervical cancer is one of the most preventable cancers when caught early. The USPSTF recommends cervical screening begin at age 21, regardless of sexual activity history. From 21 to 29, a Pap smear every three years is the standard approach. Between ages 30 and 65, options include a Pap smear every three years, an HPV test alone every five years, or HPV co-testing every five years.

Screening generally ends at age 65 for women who have had adequate prior screening and no high-risk history. Women who have had a hysterectomy that included removal of the cervix and have no history of high-grade precancerous lesions typically do not need continued screening — but should confirm this with their provider.

Breast Cancer Screening

Mammography is the primary tool for breast cancer screening in average-risk women. The USPSTF updated its guidance in 2024, recommending that women begin biennial (every two years) mammograms starting at age 40. The decision to continue screening beyond age 74 should be made individually, in consultation with a clinician.

Women with elevated risk — due to a family history of breast cancer, a known BRCA1 or BRCA2 gene variant, or other factors — may benefit from earlier or more frequent screening, including MRI. Risk assessment conversations are an important part of primary care for women in their 30s.

For a fuller picture of cancer screenings including colonoscopy, see cancer screenings demystified.

Bone Density Screening

Osteoporosis disproportionately affects women, particularly after menopause when estrogen decline accelerates bone loss. The USPSTF recommends a DEXA scan beginning at age 65 for women without known risk factors. Women under 65 whose estimated 10-year fracture risk is equal to or greater than that of a 65-year-old white woman with no additional risk factors may also be candidates for earlier screening.

Risk factors that may prompt earlier evaluation include low body weight, smoking history, long-term corticosteroid use, and certain medical conditions. Your provider can use a validated tool — such as FRAX — to estimate fracture risk and guide the timing decision.

For more on how physical activity intersects with bone health, see bone density, exercise, and women.

Additional Screenings to Know About

Several screenings recommended for adults generally carry particular relevance for women:

• Blood pressure: Hypertension screening is recommended for all adults. Women's cardiovascular risk increases after menopause, making consistent monitoring important.
• Diabetes: The USPSTF recommends blood glucose or HbA1c screening for adults aged 35–70 who are overweight or obese. Gestational diabetes history increases future type 2 diabetes risk.
• Anxiety disorders: The USPSTF recommends screening for anxiety in women through age 64, reflecting evidence of higher prevalence in this population.
• Depression: Screening for depression is recommended for all adults, with additional attention warranted during and after pregnancy.

For a comprehensive look at how screening needs shift across life stages, see a lifelong screening calendar. Men's specific screening guidelines are covered in screenings specifically recommended for men.

This article is for general informational and educational purposes only and does not constitute medical advice. Speak with a qualified healthcare provider to determine which screenings are appropriate for your individual health history and risk profile.